Loes Stevers News Today

The biotechnology start-up Ambagon Therapeutics has raised 75 million euros (85 million dollars) in a financing round. With the money, the Dutch-American company will develop medicines that can be used to better treat cancer in the future. Ambagon was founded in 2020 on the basis of a number of years of research at TU Eindhoven by Eline Sijbesma, Loes Stevers and others.

The biotechnology start-up Ambagon Therapeutics has raised 75 million euro (85 million dollars) in a financing round. With the money, the

The biotechnology start-up Ambagon Therapeutics has raised 75 million euros (85 million dollars) in a financing round. With the money, the